SPOTLIGHT: Pharma sees big payback for Alzheimer's research

Pharma sees big payback for Alzheimer's research
According to The New York Times, a broad array of pharma and biotech companies are looking for new therapies to treat Alzheimer's, which is expected to claim millions of more victims as the populations of developed countries age. Report